Strategic choices facing the pharmaceutical industry: A case for innovation

Drug Discovery Today

Volumn 2, Issue 2, 1997, Pages 72-78

  Drews, J ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DEVELOPMENT; DRUG INDUSTRY; MANAGEMENT; MARKET; ORGANIZATION; PRODUCTIVITY; PROFIT; RESEARCH; REVIEW;

EID: 0030759661     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(96)10051-9     Document Type: Review

References (31)

1. Stille G. Von der Materia Medica zur Pharmakologie 1994 G. Braun
2. Peyer H.C. Roche- A Company History 1896–1996 1996 Editiones Roche
3. Ehrlich P. Himmelweit F. Gesammelte Arbeiten 1957 Springer
4. Ridder P. Hirzel S. Im Spiegelder Arznei 1990 Edition Universitas
5. Do We Pay Too Much for Prescriptions? Consum. Rep. 1993 668 674
6. DiMasi J.A. J. Health Econ. 10 1991 107 142
7. Mossinghoff G.J. Drug Inf. J. 29 1995 1077 1090
8. Biotech '95: The Ernst & Young Ninth Annual Report on Biotechnology Industry 1994 Ernst & Young
9. Biotech '96: The Ernst & Young Tenth Annual Report on Biotechnology Industry 1995 Ernst & Young
10. Earning a Failing Grade: A Report Card on the 1992 Drug Manufacturer Price Inflation 1993 Special Committee on Aging, United States Senate
11. The Biomedical Research and Development Price Index 1996 National Institutes of Health
12. (1980–1994) July MacInnes R. International Drug Development: Efficiency and Output 1995 Centre for Medicines Research Bethesda, MD, USA
13. Drews J. Pharm, Weekbl. Scientific Edition 12 1 1990 6 10
14. Hale D. Scrip Magazine 1996 54 56
15. Drews J. Ryser S. Drug Inf. J. 30 1996 97 108
16. Drews J. Presented as Tenth Annual Lecture for Centre for Medicines Research The Impact of Cost Containment on Pharmaceutical Research and Development 1995 Surrey, UK, (June 1995)
17. Biotechnology's Top 50 in Pharmaceuticals and Diagnostics, a Competitive Analysis POV Reports 1994 Cedar Grove Surrey, UK
18. Edwards M. Survey of Alliances and INDs of Major Medical Biotechnology Companies 1993 Recombinant Capital, Inc. NJ, USA
19. Biotech '94: The Ernst & Young Eighth Annual Report on Biotechnology Industry 1993 Ernst & Young San Francisco, CA, USA
20. Drews J. Drug News Perspect. 7 1994 133 137
21. Schumpeter J.A. Business Cycles: A Theoretical, Historical and Statistical Analysis of the Capitalist Process 1939 McGraw Hill
22. Biotechnology Medicines in Development, 1996 Survey 1996 Pharmaceutical Research and Manufacturers of America
23. Drews J. Ryser S. Hardman I.G. Goodman and Gilman's The Pharmacological Basis of Therapeutics 9th edn unpublished analysis, data obtained from 1996 McGraw Hill Washington, DC, USA
24. Wilson J.D. Harrison's Principles of Internal Medicine 12th edn 1991 McGraw Hill
25. Wright S. Genetic and Biometric Foundations 1 1968 University of Chicago Press
26. Dietrich W.F. Cell 75 1993 631 639
27. Human Genome Management Information System Human Genome News 7 1995 Oak Ridge
28. Artavanis-Tsakonas S. Matsuno K. Fortini M.E. Science 268 1995 225 232
29. Bradley A. Biotechnology 10 1992 534 539
30. Trends in Pharmaceutical R&D 1994 Centre for Medicines Research TN, USA
31. New Drug Approvals in 1955 1996 Pharmaceutical Research and Manufacturers of America Surrey, UK